Redwood Toxicology Laboratory Introduces Comprehensive Test Panel; Tests 66 Drugs, Covering 600+ Prescription Brand Names
SANTA ROSA, California, December 1, 2008 - Redwood Toxicology Laboratory, Inc. (RTL), a subsidiary of Inverness Medical Innovations, Inc. (AMEX: IMA), today launched a comprehensive test panel that identifies 66 drugs. This panel covers over 600 brand name prescription drugs including prescription narcotics/opiates, central nervous system depressants, antidepressants and stimulants. Commonly abused illicit drugs, alcohol (ethanol) and specimen validity are also included.
RTL's new comprehensive test panel will be ideal for a variety of industries, including healthcare professionals, pain management, addiction treatment, workplace, criminal justice, schools, colleges, forensics and third party administrators.
"Most people who take prescription medications do so responsibly," said Albert Berger, VP, Drugs of Abuse/Toxicology, RTL. "However, a significant number of people nationwide are using prescription drugs for non-medical reasons. Our new test offers the most comprehensive drug panel ever offered by RTL."
"RTL's comprehensive panel is screened and confirmed using gas chromatography/ mass spectrometry (GC/MS), the industry 'gold standard' of testing methods," said Wayne Ross, Chief Toxicologist, RTL. "We are proud and excited to offer these exceptionally thorough GC/MS methodologies to screen and confirm a wide variety of prescription drugs, illicit drugs and alcohol."
Both Berger and Ross emphasized that the new comprehensive panel is well suited for a variety of environments that have prevalent access to addictive prescription drugs. The test will help limit workplace liability and employee expenses, and facilitate pain medication monitoring; all at a very attractive cost to administrators.
About Inverness Medical
By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse, and women's health. Inverness is headquartered in Waltham, Massachusetts. For additional information on Inverness Medical Innovations, please visit www.invernessmedical.com.
Redwood Toxicology Laboratory, Inc., a subsidiary of Inverness Medical Innovations, Inc. (AMEX: IMA), is a federally certified drug-testing laboratory. RTL offers comprehensive, low-cost drug testing and delivers the certainty of science, the dependability of proven processes and the assurance of legally defensible results. Along with the Reditest® substance abuse screening devices, RTL offers complete drug screening solutions. For more information contact: Suzanne Bertolucci, 800-255-2159 ext. 4369.
Redwood Toxicology Laboratory™ and Reditest® are trademarks of the Inverness Medical group of companies.